CatalystPit

TAKTAKEDA PHARMACEUTICAL CO LTD

NYSE · Pharmaceutical Preparations
Last close $18.19 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-09-15 · Duprey Lauren Rusckowski (Chief Transformation Officer) · SELL
  • 2026-09-03 · Plump Andrew Stewart (President, R&D) · SELL
  • 2026-08-21 · Plump Andrew Stewart (President, R&D) · SELL
  • 2026-08-19 · Greenway Nicola Deidre Petal (Chief Human Resources Officer) · SELL
  • 2026-08-12 · Shannon Elaine Mary (Pres., Global Supply & Quality) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders421
Shares held107,665,232
Value$1.70B
Percent of shares outstanding6.91%
As of quarter end2026-06-30
RECENT NEWS
  • Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?
  • Takeda Pharmaceutical presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
TAKEDA PHARMACEUTICAL CO LTD (TAK) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit